Cuba and China are working together to develop a new vaccine called the PanCorona which will be effective against new variants of COVID-19. The Chinese website Xinhua reported that scientists from Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) ... More »
The first trial of COVID vaccine approved for use in children between the ages of 5 and 18 will soon begin, the Director of Research at the Finlay Vaccine Institute (IFV), Dagmar García Rivero announced. She said the documentation is being prepared for the reg... More »
Phase III clinical trials of Cuba’s Soberana 02 vaccine for COVID-19 from the Finlay Vaccine Institute will begin after receiving approval from Cuba’s regulatory authority, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED). Sobe... More »
Production of the Soberana 02 vaccine, Cuba’s first COVID vaccine, also the first in Latin America, has begun on a large-scale at Cuba’s national plant for biological preparations (BioCen), located on Havana’s outskirts. Around 45,000 people will be vaccinated... More »
Cuba’s COVID vaccines are headed to final clinical trials between March and May, and at some future date may be made available to foreigners visiting the island, says Dr. Eduardo Martínez, Díaz, President of BioCubaFarma. Dr. Martínez Díaz appeared on Cuban te... More »
Cuba and Iran have signed a collaboration agreement for a joint project to carry out Phase III clinical trials of the Soberana 02 Covid-19 vaccine in Iran. The Middle Eastern nation is experiencing a high incidence of infection. The low incidence and low morta... More »
Cuban President Miguel Díaz-Canel met with a group of scientists and specialists on December 3 for a presentation of Cuba’s latest advances in medical equipment and technology, paving the way for technological sovereignty. Cuba’s advances in health technology ... More »
Cuba has registered its fourth COVID-19 vaccine to undergo clinical trials. The two new vaccines are known as the Mambisa (CIGB 669) and Abdala (CIGB 66) developed by the Genetic Engineering and Biotechnology Center (CIGB). The Mambisa and Abdala vaccines have... More »
After the participation of the Henry Reeve medical brigade in Lombardy supporting Italian medical personnel at the height of the COVID-19 pandemic, Italy and Cuba met to discuss further collaboration in the health sector. For this reason, the Cuban Ambassador ... More »
Cuban-British joint venture firm BioFarma Innovations made its formal debut on Friday in London in an online seminar that featured Cuban advances in biotechnology. According to the Cuban Embassy in the U.K., the seminar analyzed the advantages of the business ... More »
Itolizumab, a monoclonal antibody developed by the Center of Molecular Immunology (CIM) in collaboration with Biocon, India’s largest pharmaceutical company, received authorization to begin Phase III clinical trials in patients with COVID-19 in the United Stat... More »
His Excellency Ambassador Antony Stokes LVO attended a presentation at the Center for Genetic Engineering and Biotechnology (CIGB) to learn of the progress of five collaborative projects supported by the United Kingdom. The Ambassador was received by Dr. Eulog... More »
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.